News | January 18, 2022
Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
It is the generic version of molnupiravir
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
He has over 22 years of experience in pharmaceutical sales & business development
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
The company is focused on the development of novel treatments for RNA viruses
Leaders in scientific and industrial imaging, Atik Cameras prepares for growth as Dr Panos Kapetanopoulos is promoted to DIrector of Atik Cameras Norwich, UK
Subscribe To Our Newsletter & Stay Updated
